Mave Health raises $2.1M seed led by Blume Ventures for EEG wearable targeting India and US
Summary
Bangalore-based Mave Health raised $2.1M seed led by Blume Ventures for their wearable EEG headset targeting sleep disorders, ADHD, and cognitive decline monitoring in India and the US. The round came 16 months after a $750K pre-seed, demonstrating capital efficiency while building a working prototype. Blume is one of India's most active early-stage health tech investors with a strong track record in affordable diagnostics.
Why it matters
Mave Health represents the global democratization of neurotech — building clinical-grade EEG wearables affordable enough for the Indian healthcare market where 1 billion people have near-zero access to neurological diagnostics. India-first neurotech companies have a track record of building products that subsequently disrupt developed markets through superior cost structure.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial